- Home
- GNTA vs PETS Comparison
GNTA vs PETS Comparison
Compare GNTA & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.44
HOLD
Current Price
$3.50
Company Overview
Basic Information| Metric | GNTA | PETS |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 63.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNTA | PETS |
|---|---|---|
| Price | $1.44 | $3.50 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.20 |
| AVG Volume (30 Days) | 92.8K | ★ 7.7M |
| Earning Date | 03-30-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $198,265,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.28 | $1.57 |
| 52 Week High | $10.00 | $5.58 |
Technical Indicators
Market Signals| Indicator | GNTA | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 36.07 | 66.81 |
| Support Level | $1.28 | $3.36 |
| Resistance Level | $1.68 | $3.64 |
| Average True Range (ATR) | 0.17 | 0.40 |
| MACD | 0.02 | 0.11 |
| Stochastic Oscillator | 27.42 | 75.62 |
Price Performance
Historical Comparison GNTA
PETS
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.